Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Phenex Pharmaceuticals AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013935
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Phenex Pharmaceuticals AG (Phenex) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services which include contract screening services, NR selectivity screening and SNuRM profiling to pharmaceutical, biotechnology, veterinary medicine and food companies. It carries out research and development programs in the areas of liver and gastrointestinal diseases, chronic inflammatory diseases, diabetes, dermatology and cancer. The company develops NR resource assays for nuclear receptors in various formats. It operates in Ludwigshafen and Heidelberg. Phenex is headquartered in Ludwigshafen, Germany.

Phenex Pharmaceuticals AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Licensing Agreements 11
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Asset Transactions 12
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG – Key Competitors 14
Phenex Pharmaceuticals AG – Key Employees 15
Phenex Pharmaceuticals AG – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Key Facts 2
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenex Pharmaceuticals AG, Deals By Therapy Area, 2011 to YTD 2017 8
Phenex Pharmaceuticals AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenex Pharma Raises US$6.5 Million In Series D Financing 10
Phenex Pharma Enters Into Licensing Agreement With Janssen Biotech For Retinoid-Acid Receptor-Related Orphan Receptor Gamma t Program 11
Gilead Sciences Acquires Farnesoid X Receptor Program from Phenex Pharma 12
Phenex Pharmaceuticals AG, Key Competitors 14
Phenex Pharmaceuticals AG, Key Employees 15
Phenex Pharmaceuticals AG, Other Locations 16

★海外企業調査レポート[Phenex Pharmaceuticals AG-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Editas Medicine Inc (EDIT):企業の財務・戦略的SWOT分析
    Editas Medicine Inc (EDIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • SM Energy Company:企業のM&A・事業提携・投資動向
    SM Energy Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SM Energy Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), div …
  • Innovent Biologics Inc (1801):製薬・医療:M&Aディール及び事業提携情報
    Summary Innovent Biologics Inc (Innovent Biologics) is a biopharmaceutical company that discovers, develops and manufactures monoclonal antibodies. The company offers monoclonal antibodies such as IBI301, IBI302 and IBI303, among others. Its products are used for the treatment of non-Hodgkin’s lymph …
  • Eddingpharm Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Eddingpharm Inc (Eddingpharm) is a pharmaceutical company that manufactures and distributes medicines. The company develops products in therapeutic areas such as clinical nutrition, antibiotics, respiratory system, nephrology and cardiovascular. It offers antibiotics including vancocin, cecl …
  • G-III Apparel Group, Ltd.:企業の戦略・SWOT・財務情報
    G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report Summary G-III Apparel Group, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ecron Acunova-製薬・医療分野:企業M&A・提携分析
    Summary Ecron Acunova (EA), a subsidiary of Take Solutions Ltd. is a clinical research organization (CRO) serving big pharma companies locally. It offers clinical trial management, clinical data management services. Its services include bioavailability and bioequivalence services, Phase I to IV clin …
  • Toppan Forms Co Ltd
    Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Toppan Forms Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Translational Drug Development LLC-製薬・医療分野:企業M&A・提携分析
    Summary Translational Drug Development LLC (TD2) is a drug development organization offers oncology treatments to cancer patients. The organization offers services which include regulatory affairs services, preclinical services, clinical services, and others. It also offers in vivo services, isogeni …
  • AJ Lucas Group Ltd (AJL)
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Assystem SA (ASY)-エネルギー分野:企業M&A・提携分析
    Summary Assystem S.A. (Assystem) is a provider of engineering and innovation consultancy services. Through coordinating with clients, the company designs and develops across the life cycle products and services. It offers various R&D services range from functional analysis to commissioning by design …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Orexo AB (ORX):企業の財務・戦略的SWOT分析
    Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Express Scripts Holding Co (ESRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Express Scripts Holding Company (Express Scripts) is a pharmacy benefit management (PBM) company. It provides integrated pharmacy-benefit management services such as home delivery pharmacy services, specialty benefit management, network-pharmacy claims processing, formulary management, and m …
  • Jupiter Telecommunications Co Ltd:企業の戦略的SWOT分析
    Jupiter Telecommunications Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Astellas Pharma Inc.:企業の戦略・SWOT・財務分析
    Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report Summary Astellas Pharma Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Saudi Telecom Company:企業の戦略・SWOT・財務分析
    Saudi Telecom Company - Strategy, SWOT and Corporate Finance Report Summary Saudi Telecom Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xped Ltd (XPE):電力:M&Aディール及び事業提携情報
    Summary Xped Ltd (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. The …
  • ManTech International Corporation:企業の戦略・SWOT・財務情報
    ManTech International Corporation - Strategy, SWOT and Corporate Finance Report Summary ManTech International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • PT Elnusa Tbk (ELSA):企業の財務・戦略的SWOT分析
    Summary PT Elnusa Tbk (PT Elnusa), a subsidiary of PT Pertamina (Persero), is an oil and gas company that offers geo science services, and drilling and oilfield services. The company's geo science services include seismic data acquisition, seismic data measurement, seismic data processing, and non s …
  • Vail Resorts Inc:企業の戦略・SWOT・財務情報
    Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report Summary Vail Resorts Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆